Biomarkers Associated with Thrombosis in Patients with Peripherally Inserted Central Catheter: A Systematic Review

Patrícia Cristina Cardoso1, Eneida Rejane Rabelo-Silva1,2,3, Patricia Martins Bock4

  • 1Graduate Program in Cardiology and Cardiovascular Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-003, RS, Brazil.

PubMed

Insights

High D-dimer and platelet levels indicate a risk for deep vein thrombosis (DVT) in patients with peripherally inserted central catheters (PICCs). Other tested biomarkers were not associated with PICC-related DVT.

Area of Science:

  • Biomedical research
  • Clinical diagnostics
  • Vascular medicine

Background:

  • Plasma biomarkers aid in estimating risk and diagnosing deep vein thrombosis (DVT).
  • Peripherally inserted central catheters (PICCs) are associated with DVT risk.
  • Identifying reliable biomarkers for PICC-related DVT is crucial for patient management.

Purpose of the Study:

  • To systematically review and meta-analyze the association between various biomarkers and PICC-related DVT.
  • To identify biomarkers reflecting blood system activation, vascular complications, and inflammation in PICC-DVT.
  • To determine the diagnostic or prognostic value of these biomarkers.

Main Methods:

  • Systematic literature search of seven electronic databases up to December 2022.
  • Inclusion of studies comparing patients with and without PICC-related DVT reporting biomarker levels.
  • Quality assessment using Newcastle-Ottawa Scale and meta-analysis of findings.

Main Results:

  • Twenty-eight studies were included in the analysis.
  • Elevated D-dimer levels were significantly associated with PICC-related DVT (p=0.04).
  • Increased platelet counts were also linked to PICC-related DVT (p=0.02).

Conclusions:

  • High D-dimer and platelet levels are associated with DVT in patients with PICCs.
  • Biomarkers including APTT, fibrinogen, FDP, glucose, hemoglobin, HbA1c, INR, PT, PF1.2, TAT, and WBC were not found to be related to PICC-DVT development.
  • Further research may refine the role of D-dimer and platelets in PICC-DVT risk stratification.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
121
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763